Cancer News
Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
Purpose: Intermediate-risk prostate cancer patients represent the largest of the risk groups and comprise a heterogeneous population of patients with variable prognoses...